You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 6, June 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Evidence-Based Dermatology: Review
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Odds Ratios and Relative Risks

Michael Bigby, MD

Arch Dermatol. 2000;136:770-772.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ODDS RATIOS and relative risks are commonly used to express results in clinical studies. The results of cohort studies and case-control studies are best expressed as relative risks and odds ratios, respectively. The use and interpretation of these ratios are the subject of this brief review.

In a cohort study, a group of individuals exposed to an agent are compared with an appropriately selected control group of individuals who are not exposed. Both groups are observed until an event of interest occurs or for a prespecified time period. The association of exposure and outcome is expressed as the relative risk (Table 1). Assuming that a study is unbiased, the relative risk is interpreted as follows: A relative risk of 1 implies no association. If the relative risk is greater than 1, and its 95% confidence interval does not include 1, then the result implies a . . . [Full Text of this Article]

Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Mass



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

A Remarkable Result of a Double-Masked, Placebo-Controlled Trial of Erythromycin in the Treatment of Pityriasis Rosea
Michael Bigby
Arch Dermatol. 2000;136(6):775-776.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The (relative) risks of using odds ratios.
Katz
Arch Dermatol 2006;142:761-764.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.